• Subscribe Now
  • Cannabis News
    • Business News
    • Adult Use
    • Medical
    • Policy & Legislation
    • Hemp & CBD
    • International
  • Insights
    • Featured Announcements
    • Q&A Interviews
    • Podcasts
    • Vocabulary
  • Resources
    • Service Providers
    • Cannabis Brands
    • Dispensaries
    • Upcoming Events
  • Connect
    • Become a Subscriber
    • About Ganjapreneur
    • Contact Us
    • Partner With Us
    • Submit an Announcement
  • Subscriber Login
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube
Skip to content
  • Subscriber Login
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube
Ganjapreneur

Ganjapreneur

Cannabis Business Information Since 2014

  • Cannabis News
    • Business News
    • Adult Use
    • Medical
    • Policy & Legislation
    • Hemp & CBD
    • International
  • Insights
    • Featured Announcements
    • Q&A Interviews
    • Podcasts
    • Vocabulary
  • Resources
    • Service Providers
    • Cannabis Brands
    • Dispensaries
    • Upcoming Events
  • Connect
    • Become a Subscriber
    • About Ganjapreneur
    • Contact Us
    • Partner With Us
    • Submit an Announcement
  • Subscribe Now
  • News Categories
  • Latest News
  • Business
  • Policy & Legislation
  • Medical Cannabis
  • Adult Use
  • Hemp & CBD
Home //
Epilepsy

Epilepsy is a neurological disorder associated with abnormal electrical activity in the brain. The disorder can bring on loss of consciousness, convulsions, or episodes of sensory disturbance. Cannabis research has shown that the plant may help alleviate some of these symptoms, these articles explain more on that topic:


EU Approves Epidiolex for Childhood Seizure Disorders

Cannabis PolicyInternational Cannabis NewsMedical CannabisNews Briefs
by TG BranfaltSeptember 24, 2019October 21, 2024

UK Health Institute Rejects CBD As Epilepsy Treatment

Cannabis PolicyInternational Cannabis NewsMedical CannabisNews Briefs
by TG BranfaltAugust 27, 2019October 21, 2024

Washington Gov. Signs Two MMJ Improvements Into Law

Cannabis PolicyMedical CannabisNews Briefs
by Graham AbbottMay 7, 2019July 3, 2025

DEA Reschedules CBD Medication to Schedule 5

Medical CannabisNews Briefs
by Graham AbbottSeptember 27, 2018July 3, 2025

Study Expounds CBD’s Effectiveness vs. Seizure Disorders

Medical CannabisNews BriefsScience & Research
by Graham AbbottSeptember 10, 2018July 3, 2025

Whole-Plant CBD Extract Fights Epilepsy Better Than Refined CBD, Study Says

Medical CannabisNews BriefsScience & Research
by Guest ContributorAugust 29, 2018July 3, 2025
|

United Kingdom Legalizes Medical Cannabis

Cannabis PolicyInternational Cannabis NewsMedical CannabisNews Briefs
by Graham AbbottJuly 26, 2018July 3, 2025

Mother Carrying Epilepsy Medication is First Person to Bring Cannabis Legally Into UK

International Cannabis NewsMedical CannabisNews Briefs
by Graham AbbottJuly 11, 2018July 3, 2025

FDA Approves CBD-Based Epidiolex

Cannabis PolicyMedical CannabisNews Briefs
by Graham AbbottJune 25, 2018July 3, 2025

UK Home Office Returns Epileptic Boy’s Cannabis Medication After It Was Confiscated at Border

International Cannabis NewsMarijuana CultureMedical CannabisNews Briefs
by Graham AbbottJune 18, 2018July 3, 2025

Posts pagination

Newer posts 1 2 3 Older posts

Featured Subscriber:

Ganjapreneur is made possible by our business subscribers. Subscribe today

Cannabis News

  • Latest News
  • Business
  • Policy & Legislation
  • Medical Cannabis
  • Adult Use
  • Hemp & CBD

Insights

  • Podcasts
  • Q&A Interviews
  • Featured Announcements
  • Science & Research
  • Vocabulary

Resources

  • Services & Equipment
  • Cannabis Brands
  • Dispensaries
  • Upcoming Events

US Markets

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Iowa
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • Washington DC
  • West Virginia
  • Wisconsin
  • Wyoming

International

  • View All
  • Amsterdam
  • Asia
  • Argentina
  • Australia
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • Guam
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Morocco
  • New Zealand
  • Puerto Rico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Thailand
  • Ukraine
  • Uruguay

Ganjapreneur

Grassroots cannabis business intelligence.

  • About us
  • Contact us
  • Become a subscriber
  • Partner with us
© 2025 Ganjapreneur Site by Bluedream
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube

All rights reserved. // Terms of Use // Advertising Policy // Privacy Policy


DISCLAIMER: Ganjapreneur.com is intended as an educational resource for law-abiding professionals and those who are curious about entrepreneurial and/or investment opportunities in emerging markets. We do not offer investment advice, and we encourage all visitors and readers to do their own due dilligence before investing in any of the companies or markets that we write about. Be advised that possessing, using, distributing and selling cannabis are all federal crimes in the United States of America and the articles, pages, links, and other types of information on this site are not intended to assist you in violating federal law. Ganjapreneur.com and all associated entities and individuals are not responsible for third party content and/or links published on this website.